Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025

The global phenylketonuria treatment market size is expected to reach USD 851.0 million by 2030, registering a CAGR of 9.4% from 2025 to 2030. Rising prevalence of PKU across the world and favorable government regulations are the factors expected to spur the market growth over the forecast period.

For instance, according to the FDA, in 2018, phenylketonuria affected about 1 in 10,000 to 15,000 people in U.S. Furthermore, according to the Orphanet, it was estimated that 1 in 10,000 newborns in Europe is suffering from PKU. The target disease is highly prevalent in European countries, such as Italy, Ireland, and Turkey. It was estimated that around 1 in 4000 individuals in Turkey were diagnosed with PKU.

Various awareness programs conducted by private and public organizations are also projected to fuel market growth. Some of the organizations conducting such programs are SickKids, Children’s Hospital of Wisconsin, CHOC Children’s, and Boston Children’s Hospital. These programs aim to promote optimal emotional, developmental, and physical health PKU patients.

Furthermore, continuous R&D for the disease treatment is estimated to enhance the market growth. For instance, Synlogic, Inc.’s SYNB1618 drug is undergoing Phase 1/2a clinical trials and also received fast-track designation from FDA. In addition, other companies, such as Rubius Therapeutics, Inc., Retrophin, Inc., and Homology Medicines, Inc. are also conducting research to develop novel therapies, such as oral, enzyme therapy, gene therapy.

Availability of reimbursement policies for high-cost treatments of PKU is also projected to boost the market growth. Kuvan is currently approved for use and reimbursed in many European countries, such as Germany, Belgium, France, Italy, and Austria. Furthermore, increasing number of funding programs for R&D by various organizations is anticipated to drive the market. For instance, the National PKU Alliance provides funding to research projects that helps in promoting advances in the management and treatment of PKU.

Phenylketonuria Treatment Market Report Highlights

Palynziq accounted for the largest share of 67.9% in 2024 and is also expected to grow at a significant CAGR over the forecast period.
North America dominated the phenylketonuria treatment market in 2024 owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and favorable government regulations
Europe region is expected to exhibit the fastest CAGR over the forecast period owing to rising R&D activities for the development of new PKU drugs

Why should you buy this report?

Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
Competitive Landscape: Explore the market presence of key players worldwide.
Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

Market intelligence to enable effective decision-making
Market estimates and forecasts from 2018 to 2030
Growth opportunities and trend analyses
Segment and regional revenue forecasts for market assessment
Competition strategy and market share analysis
Product innovation listing for you to stay ahead of the curve
COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug
1.2.2. Mode of Administration
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Phenylketonuria Treatment Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis

Chapter 4. Phenylketonuria Treatment Market: Drug Business Analysis

4.1. Drug Market Share, 2024 & 2030
4.2. Drug Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug, 2018 to 2030 (USD Million)
4.4. Kuvan
4.4.1. Kuvan market, 2018 - 2030 (USD Million)
4.5. Palynziq
4.5.1. Palynziq market, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Phenylketonuria Treatment Market: Mode of Administration Business Analysis

5.1. Mode of Administration Market Share, 2024 & 2030
5.2. Mode of Administration Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Mode of Administration, 2018 to 2030 (USD Million)
5.4. Oral Administration
5.4.1. Oral administration market, 2018 - 2030 (USD Million)
5.5. Parenteral Administration
5.5.1. Parenteral administration market, 2018 - 2030 (USD Million)

Chapter 6. Phenylketonuria Treatment Market: Regional Estimates & Trend Analysis by Drug and Mode of Administration

6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Denmark phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework
6.5.8.3. Competitive insights
6.5.8.4. Sweden phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework
6.5.9.3. Competitive insights
6.5.9.4. Norway phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Japan phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. China phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Australia
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. Australia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. South Korea phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive insights
6.6.7.4. Thailand phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. South Africa phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. Saudi Arabia phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. UAE phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key country dynamics
6.8.5.2. Regulatory framework
6.8.5.3. Competitive insights
6.8.5.4. Kuwait phenylketonuria treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. BioMarin
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Synlogic
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Travere Therapeutics, Inc.
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. DAIICHI SANKYO COMPANY, LIMITED.
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Codexis, Inc.
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. SOM BIOTECH
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Homology Medicines, Inc. (Q32 Bio Inc.)
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global phenylketonuria treatment market, by region, 2018 - 2030 (USD Million)
Table 4 Global phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 5 Global phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 6 North America Phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 7 North America phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 8 North America phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 9 U.S. phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 10 U.S. phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 11 Canada phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 12 Canada phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 13 Mexico phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 14 Mexico phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 15 Europe phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 16 Europe phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 17 Europe phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 18 UK phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 19 UK phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 20 Germany phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 21 Germany phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 22 France phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 23 France phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 24 Italy phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 25 Italy phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 26 Spain phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 27 Spain phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 28 Denmark phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 29 Denmark phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 30 Sweden phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 31 Sweden phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 32 Norway phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 33 Norway phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 34 Asia Pacific phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 36 Asia Pacific phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 37 Japan phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 38 Japan phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 39 China phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 40 China phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 41 India phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 42 India phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 43 Australia phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 44 Australia phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 45 South Korea phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 46 South Korea phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 47 Thailand phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 48 Thailand phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 49 Latin America phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 51 Latin America phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 52 Brazil phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 53 Brazil phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 54 Argentina phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 55 Argentina phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Phenylketonuria treatment market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 59 South Africa phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 60 South Africa phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 63 UAE phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 64 UAE phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)
Table 65 Kuwait phenylketonuria treatment market, by drug, 2018 - 2030 (USD Million)
Table 66 Kuwait phenylketonuria treatment market, by mode of administration, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Phenylketonuria treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Drug outlook (USD Million)
Fig. 10 Mode of administration outlook
Fig. 11 Competitive landscape
Fig. 12 Phenylketonuria treatment market dynamics
Fig. 13 Phenylketonuria treatment market: Porter’s five forces analysis
Fig. 14 Phenylketonuria treatment market: PESTLE analysis
Fig. 15 Phenylketonuria treatment market: Drug segment dashboard
Fig. 16 Phenylketonuria treatment market: Drug market share analysis, 2024 & 2030
Fig. 17 Kuvan market, 2018 - 2030 (USD Million)
Fig. 18 Palynziq market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Phenylketonuria treatment market: Mode of administration segment dashboard
Fig. 21 Phenylketonuria treatment market: Mode of administration market share analysis, 2024 & 2030
Fig. 22 Oral administration market, 2018 - 2030 (USD Million)
Fig. 23 Parenteral administration market, 2018 - 2030 (USD Million)
Fig. 24 Phenylketonuria treatment market revenue, by region
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 Regional marketplace: Key takeaways
Fig. 27 North America phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 28 U.S. country dynamics
Fig. 29 U.S. phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 30 Canada country dynamics
Fig. 31 Canada phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 32 Mexico country dynamics
Fig. 33 Mexico phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 34 Europe phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 35 UK country dynamics
Fig. 36 UK phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 37 Germany country dynamics
Fig. 38 Germany phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 39 France country dynamics
Fig. 40 France phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 41 Italy country dynamics
Fig. 42 Italy phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 43 Spain country dynamics
Fig. 44 Spain phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 45 Denmark country dynamics
Fig. 46 Denmark phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 47 Sweden country dynamics
Fig. 48 Sweden phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 49 Norway country dynamics
Fig. 50 Norway phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 52 Japan country dynamics
Fig. 53 Japan phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 54 China country dynamics
Fig. 55 China phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 56 India country dynamics
Fig. 57 India phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 58 Australia country dynamics
Fig. 59 Australia phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 60 South Korea country dynamics
Fig. 61 South Korea phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 62 Thailand country dynamics
Fig. 63 Thailand phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 64 Latin America phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 65 Brazil country dynamics
Fig. 66 Brazil phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 67 Argentina country dynamics
Fig. 68 Argentina phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 69 MEA phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 70 South Africa country dynamics
Fig. 71 South Africa phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia country dynamics
Fig. 73 Saudi Arabia phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 74 UAE country dynamics
Fig. 75 UAE phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 76 Kuwait Key country dynamics
Fig. 77 Kuwait phenylketonuria treatment market, 2018 - 2030 (USD Million)
Fig. 78 Company categorization
Fig. 79 Company market position analysis
Fig. 80 Strategic framework

Companies Mentioned

BioMarin
Synlogic
Travere Therapeutics, Inc.
DAIICHI SANKYO COMPANY, LIMITED.
Codexis, Inc.
SOM BIOTECH
Homology Medicines, Inc. (Q32 Bio Inc.)

Methodology

LOADING...

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5865EUR$5,950USD£4,850GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6851EUR$6,950USD£5,665GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8822EUR$8,950USD£7,295GBP

Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025 - 2030

Phenylketonuria Treatment Market Report Highlights

Why should you buy this report?

This report addresses:

Table of Contents

Companies Mentioned

Methodology

Phenylketonuria Treatment Market Report Highlights

Why should you buy this report?

This report addresses:

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Phenylketonuria Treatment Market by Route of Administration, Product, Distribution - Global Forecast 2025-2030

Phenylketonuria - Market Insight, Epidemiology And Market Forecast - 2032

KUVAN (Sapropterin Hydrochloride), Drug Insight and Market Forecast - 2032

Phenylketonuria Treatment - Global Strategic Business Report

Phenylketonuria Treatment Market Report and Forecast 2023-2031